Perioperative Management of Patients with Von Willebrand's Disease

Overview

Journal Can J Anaesth

Specialty Anesthesiology

Date 1990 Apr 1

PMID 2182206

Citations 4

Authors

C B Cameron

N Kobrinsky

Affiliations

Soon will be listed here.

Abstract

This review focuses on the pathophysiology of the Factor VIII molecule as it relates to Von Willebrand's disease. Three major categories of Von Willebrand's disease are identified. The perioperative diagnosis and management of all categories are reviewed. 1-Deamino-8-D-arginine vasopressin (DDAVP) is presented as an alternative to the transfusion of blood and blood products for the management of a bleeding diathesis.

Citing Articles

A case report on the successful perioperative management of hepatectomy for hepatocellular carcinoma in a patient with von Willebrand disease.

Sato K, Kuroda S, Kobayashi T, Shimizu S, Ohira M, Tahara H Int J Surg Case Rep. 2018; 44:131-134.

PMID: 29501017 PMC: 5910518. DOI: 10.1016/j.ijscr.2018.02.033.

Redo-redo aortic root replacement with a mechanical valved conduit in a patient with von Willebrand's disease: Case report.

Shaikhrezai K, Bashir U, Millar S, Anderson J, Brackenbury E J Cardiothorac Surg. 2010; 5:59.

PMID: 20707891 PMC: 2933600. DOI: 10.1186/1749-8090-5-59.

The obstetrical anaesthesia assessment clinic: a review of six years experience.

Rosaeg O, Yarnell R, Lindsay M Can J Anaesth. 1993; 40(4):346-56.

PMID: 8485795 DOI: 10.1007/BF03009634.

Patient-controlled analgesia (PCA) using fentanyl in a parturient with a platelet function abnormality.

Kleiman S, Wiesel S, Tessler M Can J Anaesth. 1991; 38(4 Pt 1):489-91.

PMID: 2065415 DOI: 10.1007/BF03007585.

References

Jaffe E, HOYER L, Nachman R . Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest. 1973; 52(11):2757-64. PMC: 302543. DOI: 10.1172/JCI107471. View

Jenkins C, Phillips D, Clemetson K, Meyer D, LARRIEU M, LUSCHER E . Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease. J Clin Invest. 1976; 57(1):112-24. PMC: 436631. DOI: 10.1172/JCI108251. View

Mannucci P, Ruggeri Z, Pareti F, Capitanio A . 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet. 1977; 1(8017):869-72. DOI: 10.1016/s0140-6736(77)91197-7. View

Mannucci P, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, MECCA G . Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med. 1983; 308(1):8-12. DOI: 10.1056/NEJM198301063080102. View

Green D, POTTER E . Failure of AHF concentration to control bleeding in von Willebrand's disease. Am J Med. 1976; 60(3):357-60. DOI: 10.1016/0002-9343(76)90751-8. View

Mannucci P, Canciani M, Rota L, Donovan B . Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease. Br J Haematol. 1981; 47(2):283-93. DOI: 10.1111/j.1365-2141.1981.tb02789.x. View

Weinstein M, Deykin D . Comparison of factor VIII-related von Willebrand factor proteins prepared from human cryoprecipitate and factor VIII concentrate. Blood. 1979; 53(6):1095-105. View

HOYER L . The factor VIII complex: structure and function. Blood. 1981; 58(1):1-13. View

Fay P, Chavin S, Schroeder D, Young F, Marder V . Purification and characterization of a highly purified human factor VIII consisting of a single type of polypeptide chain. Proc Natl Acad Sci U S A. 1982; 79(23):7200-204. PMC: 347306. DOI: 10.1073/pnas.79.23.7200. View

10.

OWEN Jr C, BOWIE E, Fass D . Generation of factor VIII coagulant activity by isolated, perfused neonatal pig livers and adult rat livers. Br J Haematol. 1979; 43(2):307-15. DOI: 10.1111/j.1365-2141.1979.tb03754.x. View

11.

Ruggeri Z, Mannucci P, Lombardi R, Federici A, ZIMMERMAN T . Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes. Blood. 1982; 59(6):1272-8. View

12.

Kobrinsky N, Letts R, Patel L, Israels E, Monson R, Schwetz N . 1-Desamino-8-D-arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double-blinded, controlled trial. Ann Intern Med. 1987; 107(4):446-50. DOI: 10.7326/0003-4819-107-4-446. View

13.

COOPER H, Griggs T, Wagner R . Factor VIII recombination after dissociation by CaCl12. Proc Natl Acad Sci U S A. 1973; 70(8):2326-9. PMC: 433728. DOI: 10.1073/pnas.70.8.2326. View

14.

Kobrinsky N, Israels E, Gerrard J, Cheang M, Watson C, Bishop A . Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders. Lancet. 1984; 1(8387):1145-8. DOI: 10.1016/s0140-6736(84)91393-x. View

15.

Ruggeri Z, ZIMMERMAN T . The complex multimeric composition of factor VIII/von Willebrand factor. Blood. 1981; 57(6):1140-3. View

16.

Coller B . The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility. J Clin Invest. 1978; 61(5):1168-75. PMC: 372637. DOI: 10.1172/JCI109032. View

17.

Salzman E, Weinstein M, Weintraub R, Ware J, Thurer R, Robertson L . Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. N Engl J Med. 1986; 314(22):1402-6. DOI: 10.1056/NEJM198605293142202. View

18.

Sodetz J, Paulson J, Pizzo S, McKee P . Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues. J Biol Chem. 1978; 253(20):7202-6. View

19.

Nachman R, Jaffe E . Subcellular platelet factor VIII antigen and von Willebrand factor. J Exp Med. 1975; 141(5):1101-13. PMC: 2189790. DOI: 10.1084/jem.141.5.1101. View

20.

Cornu P, LARRIEU M, Caen J, Bernard J . Transfusion studies in von Willebrand's disease: effect on bleeding time and factor VIII. Br J Haematol. 1963; 9:189-202. DOI: 10.1111/j.1365-2141.1963.tb05457.x. View